Connect with us

Health

Global Health Inequities Persist as Progress on Life Expectancy and Mortality Slows, Says WHO

Published

on

While the world has made significant strides in narrowing health disparities between rich and poor nations over the past two decades, progress is now faltering — and in some cases reversing — according to a new report by the World Health Organization (WHO).

The report, the WHO’s first comprehensive analysis on health equity since 2008, finds that although gaps in life expectancy, child mortality, and maternal health have narrowed globally, none of the agency’s long-term health targets for 2040 are currently on track to be met.

“There has been some progress narrowing health gaps between countries, but it is stalling,” said Dr. Sudhvir Singh, who leads the WHO’s equity and health unit, during a press briefing. He called for urgent action to address the underlying social, political, and economic factors driving health inequalities.

The WHO’s 2040 targets include halving the gap in life expectancy between countries, reducing adult mortality by half, slashing child deaths under age five by 90 percent, and cutting maternal mortality by 95 percent. Yet, the latest figures reveal that progress toward these goals has slowed dramatically.

A stark example is life expectancy. While people in high-income countries such as Japan enjoy an average lifespan of 84.5 years, those in countries like Lesotho live on average only 51.5 years — a gap of 33 years. The global average gap still stands at 12.5 years, well short of the WHO’s goal to reduce it to 8.2 years by 2040.

Child mortality has improved significantly, with global rates dropping from 77 deaths per 1,000 live births in 2000 to 37 in 2023. But children in low-income nations remain 13 times more likely to die before age five compared to those in wealthier countries. The WHO’s target of eight deaths per 1,000 by 2040 appears increasingly out of reach.

See also  Global Health Aid Drops to 15-Year Low as Major Donors Slash Funding

Maternal mortality has declined by 40 percent since 2000, yet the current global rate remains at 197 deaths per 100,000 live births — more than twelve times higher than the 2040 goal of just 16.

The report also highlights major disparities within countries. Poorer communities, women, ethnic minorities, and other marginalized groups continue to face worse health outcomes due to factors such as income inequality, poor access to public services, systemic discrimination, and environmental threats like climate change.

WHO officials warned that climate change alone could push up to 135 million people into extreme poverty in the next five years — further widening health gaps unless governments act decisively.

“There’s a very positive return on investment from addressing these social determinants of health,” said Singh. “And there’s a huge cost of inaction.”

Health

Portuguese Teenagers Report Lower Drug and Alcohol Use, but High-Risk Behaviour Persists

Published

on

Portuguese teenagers are reporting lower levels of alcohol and drug use and fewer problems linked to addictive behaviours, but risks are becoming increasingly concentrated among young people facing multiple personal and social difficulties, according to a new study.

The findings come from the 2024 Study on Alcohol, Tobacco, Drugs and Other Addictive Behaviours (ECATD-CAD), conducted by the Institute for Addictive Behaviours and Dependencies (ICAD). The research examines addictive behaviours among pupils aged 13 to 18 attending state schools across Portugal.

Compared with the previous study in 2019, the latest results show a consistent decline in reported problems, including violence, accidents, hospitalisations, risky sexual behaviour and other incidents with potentially serious consequences.

Researchers linked the broader improvement to several protective factors. Students reported better academic performance, closer parental supervision and fewer nights out, suggesting that changes in family and school environments may be helping reduce risky behaviour.

However, ICAD warned that the overall decline does not mean the problem has disappeared. The most serious behaviours are increasingly concentrated in a relatively small group of adolescents who face greater individual and social vulnerabilities.

Recent alcohol consumption and, particularly, illicit drug use remain strongly associated with problematic situations. Young people who use psychoactive substances report higher rates of risky sexual behaviour, violence between individuals, accidents and trouble with the police.

The report noted that these problems do not necessarily occur immediately after substance use, but the association remains significant.

Combining alcohol with illicit drugs appears to carry additional risks. Adolescents who reported recent use of both substances experienced higher levels of accidents, police-related problems, cyberbullying and risky sexual behaviour than those who consumed alcohol alone.

See also  Paris Hosts First-Ever Mocktail Competition to Promote Dry January

Alcohol use also raises concerns about why some teenagers drink. While pleasure, entertainment and socialising remain the main motivations, a significant proportion said they consumed alcohol to forget their problems. ICAD identified this as a warning sign associated with potentially harmful drinking patterns and dependence.

Cannabis use presented a mixed picture. Although most users showed no indicators of dependency risk, the proportion classified as being at high risk increased, alongside growth in the group with no identified risk.

Social media remained the main concern among behaviours not involving substances. A significant number of young people acknowledged spending excessive time on these platforms. Indicators of problematic electronic gaming remained broadly stable, while gambling for money became more prevalent among adolescents, despite a slight decline in some indicators of problematic gambling.

The study also identified differences between boys and girls. Boys were more likely to report problems with the police, risky gaming and gambling. Girls reported higher levels of problematic social media use and were more likely to use alcohol to cope with emotional difficulties.

Family circumstances and wellbeing were also important. Low academic achievement, limited parental supervision, frequent nights out and poorer physical and emotional health were associated with greater risk. Better school performance, stronger parental involvement and improved wellbeing appeared protective.

Regional differences were also evident. Alentejo recorded the highest concentration of unfavourable indicators, followed by the Azores. Lisbon, which showed the greatest vulnerability in the 2019 study, no longer held that position.

ICAD’s findings point to the need for targeted support for vulnerable adolescents, even as overall patterns of substance use and related problems improve.

Continue Reading

Health

Plague Fears Return After Russian Death, but Europe Faces Very Low Risk

Published

on

The death of a scientist in Russia’s Siberian region of Irkutsk has revived concerns about plague, but health authorities say there is currently no evidence of an outbreak or sustained transmission in Europe.

The woman died from pneumonia of unknown origin, prompting speculation that she could have contracted pneumonic plague. Russian authorities have said no plague cases have been confirmed in the region, while tests conducted on people who had contact with the woman were negative.

The World Health Organization has asked Russia for additional information about the incident and offered assistance to local health authorities.

Plague is caused by the bacterium Yersinia pestis, which remains present in wild animal populations in parts of the world. It is commonly associated with rodents and the fleas that live on them. People can become infected through bites from infected fleas, contact with tissues or bodily fluids from infected animals, or respiratory particles from people suffering from pneumonic plague.

For Spain and most of Europe, however, the current risk is considered very low. The European Centre for Disease Prevention and Control says routine transmission has not been recorded in Europe for more than five decades.

That does not mean the bacterium has disappeared. Its continued presence in animal reservoirs means isolated human infections remain possible, particularly in areas where infected wildlife and fleas are found.

Spain has maintained epidemiological surveillance despite the absence of locally acquired cases for decades. In April 2026, its Public Health Commission updated the national plague protocol, including case definitions, epidemiological information and procedures for investigating suspected infections.

See also  Polio Vaccination Campaign Concludes in Gaza Amid Conflict and Limited Access

European authorities have also been monitoring the Siberian incident. The European Union discussed the case at a Health Security Committee meeting on October 7, while the ECDC said there was no evidence of secondary cases or sustained person-to-person transmission.

The WHO has assessed the risk to the European region as very low.

Plague continues to occur in parts of Africa, Asia and the Americas. According to the WHO, most reported human cases between 2019 and 2025 were concentrated in Madagascar and the Democratic Republic of the Congo. Madagascar records bubonic plague cases during its annual epidemic season, generally from September to April. In the United States, about seven human cases are reported each year, mainly in rural areas of western states.

The disease can occur in bubonic, pneumonic or septicaemic forms. Bubonic plague usually causes fever and painful swollen lymph nodes after an infected flea bite. Pneumonic plague affects the lungs and can spread between people through respiratory particles. Septicaemic plague occurs when the infection enters the bloodstream.

Modern antibiotics can successfully treat plague, but early diagnosis is critical. Health surveillance, rapid identification and treatment remain important in preventing isolated infections from developing into wider outbreaks.

Continue Reading

Health

Optogenetics Pioneers Win 2026 Nobel Prize in Medicine

Published

on

Scientists Karl Deisseroth, Peter Hegemann and Georg Nagel have been awarded the 2026 Nobel Prize in Physiology or Medicine for their work on light-gated ion channels and optogenetics, a technique that has transformed the study of the brain.

The Nobel Assembly at Karolinska Institutet announced the award on Monday, describing the work as laying the foundation for a new era in neuroscience.

Optogenetics allows researchers to control selected cells using light, effectively providing a remote switch that can turn specific cells on or off. The technique has enabled scientists to investigate how individual neurons and neural circuits influence behaviour in living animals.

The origins of the discovery date back to Hegemann’s research more than three decades ago. While studying the single-celled alga Chlamydomonas, which moves towards light, he sought to understand how the organism detects changes in illumination.

Hegemann focused on the alga’s eyespot, a small light-sensing structure on its surface. His research and subsequent experiments identified light-sensitive proteins known as channelrhodopsins.

Hegemann later worked with Nagel at the Max Planck Institute for Biophysics in Frankfurt. The researchers inserted genes from the algae into frog egg cells and human kidney cells, demonstrating that channelrhodopsin functions as a light-controlled ion channel.

When exposed to blue light, the channel can open within about 0.2 milliseconds. Positively charged ions then enter the cell, generating an electrical signal.

Deisseroth later adapted the discovery for neuroscience. He introduced the channelrhodopsin gene into rat nerve cells and showed that blue light could activate the cells and trigger nerve signals.

He subsequently used the technique in the brains of living mice, demonstrating that researchers could control specific groups of neurons with light. Experiments showed that stimulating selected neural circuits could produce physical responses, including movements of a mouse’s whiskers, or cause sleeping animals to wake.

See also  E-Cigarette Use Rises as European Teens Turn Away from Alcohol and Drugs, Survey Finds

The method was named optogenetics in 2006 and has since become an important research tool in neuroscience.

Researchers now use it to establish direct links between neural activity and behaviour. By activating or silencing particular groups of cells, scientists can study circuits associated with fear, anxiety, reward, pain, thirst, attention and aggression.

The technique has also been used in research into conditions including depression, schizophrenia, anxiety, Alzheimer’s disease, Parkinson’s disease and epilepsy.

Per Svenningsson, chair of the Nobel Committee for Physiology or Medicine, said the discovery provides opportunities to map the brain in ways researchers could previously only imagine.

Optogenetics has also moved beyond laboratory research. Scientists are testing its potential as a treatment for retinitis pigmentosa, a genetic disorder that causes blindness through the loss of light-sensitive retinal cells.

In experimental treatments, researchers introduce genes encoding light-sensitive proteins into surviving retinal cells. In some trials, patients using specialised light-emitting goggles have been able to regain partial vision and detect high-contrast objects.

The Nobel award recognises a discovery that has given researchers an unprecedented way to investigate the relationship between brain cells, neural circuits and behaviour.

Continue Reading

Trending